An Act to repeal 450.09 (2) (b) 1. a. to d.; to renumber 450.09 (2) (b) 2. b.; to renumber and amend 450.09 (2) (b) 2. a.; to consolidate, renumber and amend 450.09 (2) (b) 1. (intro.) and 2. (intro.); to amend 450.01 (21c), 450.02 (5) and 450.09 (1) (a) of the statutes; Relating to: remote dispensing sites under the pharmacy practice law.
Impact
The anticipated impact of AB842 on state laws revolves around modernizing pharmacy practice to incorporate technological advancements in healthcare delivery. This can lead to an expanded network of pharmacies that can cater to patients who may not be able to physically visit a pharmacy. The legislation is expected to streamline the process governing how pharmaceuticals are dispensed remotely, potentially easing burdens on both patients and healthcare providers. By officially recognizing remote dispensing, the bill helps align state laws with current healthcare trends and practices.
Summary
AB842 focuses on establishing regulations for remote dispensing sites under the pharmacy practice law. This bill aims to improve access to medications, particularly in underserved areas, by allowing pharmacies to leverage technology for remote dispensing. It outlines the conditions under which these remote sites can operate, ensuring that they comply with existing pharmacy laws while promoting innovative health delivery methods. Proponents of the bill believe that by facilitating telepharmacy operations, patient outcomes can be enhanced through better access to medications, especially for those living in rural or isolated regions.
Contention
Despite the potential benefits, there are notable points of contention surrounding AB842. Critics raise concerns about patient safety and the quality of care provided through remote dispensing. There is apprehension about the potential for reduced pharmacist oversight in assessing patients' needs and managing medication therapy. Additionally, some stakeholders argue that the bill could inadvertently diminish the role of local pharmacies, leading to a concentration of power among larger pharmacy chains capable of establishing remote sites. This opposition highlights the balance that must be struck between increased access and maintaining the quality of pharmaceutical care.